On April 30th, 2018, the United States Food and Drug Administration completed a review of the Pre-Market Tobacco Product Application (PMTPA) submitted by Philip Morris International, and authorized them to market their IQOS products. The FDA came to this decision after determining that marketing these new products would not be detrimental to the health of consumers. They believe IQOS products produce fewer harmful toxicants than traditional tobacco products.
Mr. Zeller went on to say in his statement that the FDA would be monitoring the frequency of youth uptake of these devices, and that they would take all precautions necessary under the law to make sure Philip Morris prevents their access to underage citizens.
and that they would take all precautions necessary under the law to make sure Philip Morris prevents their access to underage citizens.
The PMTPA pathway requires that all tobacco companies introducing a new product demonstrate that it will not endanger public health. The application must include scientific research that supports the position of the tobacco company.
